title: Ethnic differences in bone and mineral metabolism in healthy people and patients with CKD.
abstract: Several studies have shown racial differences in the regulation of mineral metabolism, in the acquisition of bone mass and structure of individuals. In this review, we examine ethnic differences in bone and mineral metabolism in normal individuals and in patients with chronic kidney disease. Black individuals have lower urinary excretion and increased intestinal calcium absorption, reduced levels of 25(OH)D, and high levels of 1.25(OH)2D and parathyroid hormone (PTH). Body phosphorus concentration is higher and the levels of FGF-23 are lower than in whites. Mineral density and bone architecture are better in black individuals. These differences translate into advantages for blacks who have stronger bones, less risk of fractures, and less cardiovascular calcification. In the United States of America, the prevalence of kidney disease is similar in different ethnic groups. However, black individuals progress more quickly to advanced stages of kidney disease than whites. This faster progression does not translate into increased mortality, higher in whites, especially in the first year of dialysis. Some ethnicity-related variations in mineral metabolism persist when individuals develop CKD. Therefore, black patients have lower serum calcium concentrations, less hyperphosphatemia, low levels of 25(OH)D, higher levels of PTH, and low levels of FGF-23 compared with white patients. Bone biopsy studies show that blacks have greater bone volume. The rate of fractures and cardiovascular diseases are also less frequent. Further studies are required to better understand the cellular and molecular bases of these racial differences in bone mineral metabolism and thus better treat patients.
authors.affiliation: Nephrology Division, Medical School, University of São Paulo, São Paulo, Brazil.
authors.forename: Vanda
authors.initials: V
authors.lastname: Jorgetti
authors.affiliation: Nephrology Division, Medical School, University of São Paulo, São Paulo, Brazil.
authors.forename: Luciene M
authors.initials: LM
authors.lastname: dos Reis
authors.affiliation: Department of Medicine, University of Washington, Seattle, Washington DC, USA.
authors.forename: Susan M
authors.initials: SM
authors.lastname: Ott
mesh_terms: D015415:Biomarkers / Q000097:blood; D015519:Bone Density; D016723:Bone Remodeling; D001842:Bone and Bones / Q000378:metabolism* / Q000503:physiopathology; D018450:Disease Progression; D005006:Ethnicity; D000089703:Fibroblast Growth Factor-23; D050723:Fractures, Bone / Q000208:ethnology; D054624:Health Status Disparities; D006801:Humans; D008903:Minerals / Q000378:metabolism*; D011379:Prognosis; D051436:Renal Insufficiency, Chronic / Q000097:blood / Q000208:ethnology* / Q000503:physiopathology / Q000628:therapy; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors
chemical_list: D015415:Biomarkers; C000717427:FGF23 protein, human; D008903:Minerals; D000089703:Fibroblast Growth Factor-23